CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion
RITUAL
Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Isolated Chronic Total Occlusion of the Left Anterior Descending Artery: The RITUAL Study
1 other identifier
observational
302
1 country
1
Brief Summary
The aim of this study is to compare coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in the treatment of isolated chronic total occlusion (CTO) of the left anterior descending (LAD) artery in terms of short- and mid-term clinical outcomes, myocardial revascularization success, and complication rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
January 17, 2026
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedJanuary 28, 2026
January 1, 2026
4 months
January 17, 2026
January 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Procedural success
Successful completion of coronary revascularization of the left anterior descending artery without in-hospital major adverse cardiac events.
perioperatively / periprocedurally
Secondary Outcomes (1)
Major adverse cardiac events (MACCE) at 3 years
3 years
Study Arms (2)
Coronary Artery Bypass Grafting (CABG)
Patients with isolated chronic total occlusion of the left anterior descending artery who underwent coronary artery bypass graft surgery.
Percutaneous Coronary Intervention (PCI)
Patients with isolated chronic total occlusion of the left anterior descending artery who underwent percutaneous coronary intervention.
Interventions
Coronary artery bypass graft surgery performed as part of routine clinical care prior to study inclusion.
Percutaneous coronary intervention performed as part of routine clinical care prior to study inclusion.
Eligibility Criteria
The study population consists of adult patients aged 18 years or older with isolated chronic total occlusion (CTO) of the left anterior descending (LAD) coronary artery who underwent coronary revascularization with either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) as part of routine clinical care. Isolated LAD CTO was defined as a de novo or in-stent total occlusion confined to the LAD artery, without significant coronary artery disease (≥50% stenosis) in other major epicardial coronary arteries. Patients with prior coronary revascularization, multiple CTOs, severe left ventricular dysfunction, or incomplete follow-up data were excluded.
You may qualify if:
- Age 18 years or older at the time of the index procedure.
- Diagnosis of isolated chronic total occlusion (CTO) of the left anterior descending (LAD) coronary artery.
- Isolated LAD CTO defined as a de novo or in-stent total occlusion confined to the LAD artery, without significant coronary artery disease (defined as ≥50% stenosis) in other major epicardial coronary arteries, including the left circumflex (LCx), right coronary artery (RCA), or major side branches.
- No prior percutaneous coronary intervention (PCI) performed in non-LAD coronary arteries.
- Patients who underwent coronary revascularization with either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) for isolated LAD CTO.
You may not qualify if:
- History of malignancy or active malignant disease at the time of the index procedure.
- Prior coronary artery bypass grafting (CABG) or prior percutaneous coronary intervention (PCI) performed in non-LAD coronary arteries.
- Presentation with ST-segment elevation myocardial infarction (STEMI).
- Discontinuation of prescribed medical therapy by patient preference within one year after the index procedure.
- Presence of multiple chronic total occlusions (CTOs) involving more than one coronary artery.
- Significant side branch disease of the LAD requiring two bypass grafts.
- Performance of crossover stenting from the LAD into the left main coronary artery during LAD CTO-PCI.
- Treatment of LAD CTO with drug-eluting balloon (DEB) angioplasty without stent implantation.
- Left ventricular ejection fraction (LVEF) less than 30%.
- Presence of severe valvular heart disease (e.g., severe aortic or mitral stenosis or regurgitation).
- Incomplete angiographic or clinical follow-up data.
- Use of mechanical circulatory support devices due to advanced heart failure, including intra-aortic balloon pump (IABP), extracorporeal membrane oxygenation (ECMO), or left ventricular assist device (LVAD).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mersin Medicalpark Hastanesilead
- Biruni Universitycollaborator
- Mersin Training and Research Hospitalcollaborator
- Necmettin Erbakan Universitycollaborator
- Jolimont Hospitalcollaborator
- Minneapolis Heart Institutecollaborator
Study Sites (1)
Sefa SURAL
Mersin, 33010, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sefa SURAL, MD
Toros University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Cardiology
Study Record Dates
First Submitted
January 17, 2026
First Posted
January 28, 2026
Study Start
September 10, 2025
Primary Completion
December 31, 2025
Study Completion
January 15, 2026
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to the retrospective design of the study and institutional data privacy policies.